NDC 0143-9930-03 - Cefotaxime
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9930
- Requested NDC
- 0143-9930-03
- Package NDCs from labels
- 0143-9930-01, 0143-9930-10, 0143-9930-03
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
- Effective date
- 2024-04-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cefotaxime - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2024-04-11 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-11 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9930-01 | Cefotaxime | 1 in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 1 | 14 | |
| 0143-9930-10 | Cefotaxime | 10 in 1 PACKAGE | INJECTION, POWDER, FOR SOLUTION | 10 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9930-01 | EA - Each | 0143-9930 | db60b4a5-9563-4abd-951d-b927b7fdc417 | 1 | 2013-10-17 |
| 0143-9930-03 | EA - Each | 0143-9930 | 7ebfbe1b-d89c-4e79-931e-3e80eeecd1cf | 1 | 2013-02-11 |
| 0143-9930-10 | EA - Each | 0143-9930 | 99e3a29a-d578-4c7e-88cd-1bf7ab1a77f7 | 1 | 2013-10-17 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CEFOTAXIME SODIUM | ACTIVE INGREDIENT | 258J72S7TZ | CEFOTAXIME INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 10 | |
| CEFOTAXIME | ACTIVE MOIETY | N2GI8B1GK7 | CEFOTAXIME INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefotaxime | CEFOTAXIME INJECTION | SteriMax Inc. | 8efe3bd0-c43a-2bd6-e053-2a95a90a92fa | 2026-06-15 | 1656313 1656318 258J72S7TZ | |
| Cefotaxime | CEFOTAXIME | Hikma Pharmaceuticals USA Inc. | ed23b6bc-32c7-4c50-a53d-313ae78e5623 | 2024-04-11 | Warnings, Adverse reactions | ANDA065072 0143-9930-01 0143-9931-01 0143-9930-10 0143-9933-01 0143-9931-25 0143-9933-25 0143-9931 0143-9930 0143-9933 309068 1656313 1656318 7e0897ec-2275-4438-9cc5-4c951e52ad97 ed23b6bc-32c7-4c50-a53d-313ae78e5623 258J72S7TZ |
| Cefotaxime | CEFOTAXIME | Hikma Pharmaceuticals USA Inc. | ef1a6dc6-bc3d-4f09-8f92-7ff328f56561 | 2024-04-11 | Warnings, Adverse reactions | 258J72S7TZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.